Pharmaceutical News

RSS

Anti-cancer drug shows promise in treating brain injuries after stroke

A study by the Institut de Neurociències of the UAB (INc-UAB) demonstrates in animal models the benefits of vorinostat after having suffered a stroke.

28 Feb 2024

An Arm and a Leg: Wait, is Insulin cheaper now?

Pharmaceutical companies that manufacture insulin made headlines last year when they voluntarily agreed to provide discount cards that lower the monthly cost of insulin for many people to $35.

28 Feb 2024

Aston University and PDA collaboration to examine pharmacists' expanded duties in healthcare

A partnership between Aston University and the Pharmacists' Defence Association (PDA) is to examine the feasibility of extending pharmacists' duties to include more healthcare interventions, such as blood pressure checks and cholesterol screening.

27 Feb 2024

Omalizumab boosts tolerance to multiple food allergies, study finds

A study in The New England Journal of Medicine shows omalizumab increases allergen tolerance in individuals with multiple food allergies, offering a promising standalone treatment option.

26 Feb 2024

Study finds October-born kids less likely to catch flu post-vaccination

Study shows October as the optimal month for influenza vaccination in young children, aligning with CDC guidelines to maximize protection against seasonal flu.

26 Feb 2024

Study finds sharp increase in antidepressant dispensing among adolescents and young adults during COVID-19 pandemic

Antidepressant dispensing to adolescents and young adults increased sharply after the COVID-19 pandemic began – particularly among females – a new study finds.

26 Feb 2024

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

A study published in Immunity shows that antibody responses to SARS-CoV-2 infection and vaccination are long-lasting, with an initial decline followed by stabilization after seven to nine months, highlighting the effectiveness of mRNA vaccines and the importance of hybrid immunity.

25 Feb 2024

Omalizumab shows promise in preventing food allergy reactions in children, study finds

A drug can make life safer for children with food allergies by preventing dangerous allergic responses to small quantities of allergy-triggering foods, according to a new study led by scientists at the Stanford School of Medicine.

25 Feb 2024

Reevaluating the role of direct oral anticoagulants in cardiovascular treatment

Direct oral anticoagulants (DOACs) are a common treatment for patients with a wide variety of cardiovascular conditions.

23 Feb 2024

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin.

23 Feb 2024

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe switch platform and the GoCAR platform.

22 Feb 2024

Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the Aseptic Process Simulation (APS) qualification of its sterile manufacturing facility and newly available fill/finish capacity.

From Selkirk Pharma 22 Feb 2024

Machine learning enhances understanding of drug absorption

Before orally administered drugs can make their way throughout the body, they must first bind to membrane proteins called drug transporters, which carry compounds across the intestinal tract and help them reach their intended targets.

21 Feb 2024

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns

Announcing a new publication for Acta Materia Medica journal. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but pose a challenge of immune-related adverse events (irAEs), particularly endocrine toxicity, that can severely compromise patient well-being.

21 Feb 2024

Finasteride may offer life-saving benefits beyond hair loss treatment

The drug finasteride, also known as Propecia or Proscar, treats male pattern baldness and enlarged prostate in millions of men worldwide.

20 Feb 2024

Study reveals low utilization of PCSK9 inhibitors in high-risk patients

A new study published in Circulation: Cardiovascular Quality and Outcomes from the Family Heart Foundation -; a patient-centered research and advocacy nonprofit organization dedicated to improving the lives of families impacted by inherited lipid disorders and LDL-cholesterol -; revealed that utilization of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) to reduce low-density lipoprotein cholesterol (LDL-C) remains low among high-risk patients.

20 Feb 2024

New model pinpoints drug interactions in the digestive tract

Any drug that is taken orally must pass through the lining of the digestive tract. Transporter proteins found on cells that line the GI tract help with this process, but for many drugs, it's unknown which of those transporters they use to exit the digestive tract.

20 Feb 2024

New RNA therapy zilebesiran shows promise in lowering blood pressure

Previous
1
...
23
24
25
26
27
28
29
...
1433
Next

Pharmaceutical News

Anti-cancer drug shows promise in treating brain injuries after stroke

An Arm and a Leg: Wait, is Insulin cheaper now?

Aston University and PDA collaboration to examine pharmacists' expanded duties in healthcare

Omalizumab boosts tolerance to multiple food allergies, study finds

Study finds October-born kids less likely to catch flu post-vaccination

Study finds sharp increase in antidepressant dispensing among adolescents and young adults during COVID-19 pandemic

SARS-CoV-2-infection and vaccine-induced antibodies wane initially but stabilize for lasting protection

Omalizumab shows promise in preventing food allergy reactions in children, study finds

Reevaluating the role of direct oral anticoagulants in cardiovascular treatment

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA

Machine learning enhances understanding of drug absorption

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns

Finasteride may offer life-saving benefits beyond hair loss treatment

Study reveals low utilization of PCSK9 inhibitors in high-risk patients

New model pinpoints drug interactions in the digestive tract

New RNA therapy zilebesiran shows promise in lowering blood pressure

FDA approves omalizumab for food allergy reactions based on NIH research

Investigative report reveals growing delays in complaint processing times against drug companies

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News